Comparative Efficacy of Intranasal Corticosteroids and Antihistamines in Enhancing Paediatric Quality of Life in Allergic Rhinoconjunctivitis

Summary Daily intranasal corticosteroids improved quality of life most in adolescents (12–18 years) with seasonal allergic rhinoconjunctivitis. Antihistamines showed greater quality‐of‐life improvement than intranasal corticosteroids in children (6–11 years).